View Older Stories View More Recent Stories
-
Gladstone Investment Corporation Announces Closing of Offering of 2,300,000 Shares of its 6.25% Series D Cumulative Term Preferred Stock for Gross Proceeds of Approximately $57.5 million
-
Notable Analyst Rating Changes 9/26: (DBD) (ETE) (ANDE) Upgraded; (DRH) (NTAP) (LYG) Downgraded
-
Brandon Eck joins Mufson Howe Hunter as a Managing Director & Head of Technology Services
-
Janney Montgomery Scott Upgrades Applied Genetic Technologies Corp. (AGTC) to Neutral
-
Janney Montgomery Scott Starts RLJ Lodging Trust (RLJ) at Buy
-
Janney Montgomery Scott Starts Felcor Lodging Trust (FCH) at Buy
-
Pre-Open Stock Movers 09/23: (MIFI) (BATS) (TWTR) Higher; (ENPH) (IPCI) (APRI) Lower (more...)
-
Janney Montgomery Scott Upgrades BioDelivery Sciences International (BDSI) to Buy
-
Janney Montgomery Scott Upgrades CSI Compressco LP (CCLP) to Buy
-
Chesapeake Utilities (CPK) Prices 835.2k Stock Offering at $62.26/Share
-
Chesapeake Utilities Corporation Prices Public Offering of Common Stock
-
Chesapeake Utilities (CPK) Announces $52M Common Stock Offering
-
Chesapeake Utilities Corporation Announces Common Stock Offering
-
Janney Montgomery Scott Downgrades Clovis Oncology (CLVS) to Neutral
-
Janney Montgomery Scott Starts Golub Capital BDC (GBDC) at Neutral
-
Gladstone Investment Corporation Prices Preferred Stock Offering
-
Janney Montgomery Scott Upgrades Sarepta Therapeutic (SRPT) to Buy
-
Gladstone Investment Corporation Launches New Term Preferred Stock Offering
-
Janney Montgomery Scott Starts Watts Waters (WTS) at Neutral
-
Janney Starts Martin Midstream Partners (MMLP) at Neutral
-
Janney Montgomery Scott Remains bullish on Six Flags Entertainment (SIX)
-
Depomed (DEPO): August Prescription Data Tracking At High End Of Estimates - Janney
-
Janney Montgomery Scott Starts Brooks Automation Inc. (BRKS) at Buy
-
Janney Starts BioLife Solutions (BLFS) at Neutral
-
Monmouth Real Estate Investment Corporation Announces Closing Of Preferred Stock Offering
-
Janney Montgomery Scott Downgrades Applied Genetic Technologies Corp. (AGTC) to Sell
-
Janney Montgomery Scott Downgrades XL Group plc (XL) to Neutral
-
Janney Montgomery Scott Starts Monogram Residential Trust (MORE) at Buy
-
Janney Montgomery Scott Starts Spirit Realty Capital (SRC) at Buy
-
Monmouth Real Estate Investment Corporation Announces Pricing Of Preferred Stock Offering
-
Monmouth Real Estate Investment Corporation Announces Pricing Of Preferred Stock Offering
-
Monmouth Real Estate Investment Corporation Announces Public Offering Of Preferred Stock
-
Monmouth Real Estate Investment Corporation Announces Public Offering Of Preferred Stock
-
Janney Montgomery Scott Reiterates Buy on Cedar Fair L.P. (FUN) After Meeting with Management
-
Janney Montgomery Scott Starts CONE Midstream Partners, LP (CNNX) at Buy
-
Notable Analyst Rating Changes 8/31: (PSTG) (PNC) (KOS) Upgraded; (MOS) (DGX) (INDB) Downgraded
-
Janney Montgomery Scott Downgrades Stewart Information Services (STC) to Sell
-
Janney Montgomery Scott Starts Galapagos NV (GLPG) at Buy
-
Notable Analyst Rating Changes 8/29: (CBL) (ATI) (KS) Upgraded; (HAYN) (KEY) (SQ) Downgraded
-
Janney Montgomery Scott Starts Recro Pharma (REPH) at Buy
-
Notable Analyst Rating Changes 8/25: (LLL) (RIG) (NFLX) Upgraded; (S) (OZM) (DDR) Downgraded
-
Janney Montgomery Scott Starts Jazz Pharmaceuticals (JAZZ) at Neutral
-
Janney Reiterates Bullish View on Six Flags (SIX) Following Great America Tour
-
Hospitality Properties Trust Announces Underwriters’ Exercise of Option to Purchase Additional Shares
-
Janney Montgomery Scott Starts Ferrellgas Partners LP (FGP) at Neutral
-
Triangle Capital Corporation Announces Closing of Over-Allotment Option in Connection With Public Offering of Common Stock
-
Sotherly Hotels Inc. Announces Closing of Upsized Offering of Series B Cumulative Redeemable Perpetual Preferred Stock
-
Janney Montgomery Scott Starts Investors Real Estate Trust (IRET) at Buy
-
Recro Pharma Announces Closing of Public Offering of Common Stock
-
Janney Montgomery Scott Downgrades Cerulean Pharma (CERU) to Neutral

